(ALKS:Consolidated Issue Listed on NASDAQ Global Select )
Earnings & Estimates Summary - ALKERMES PLC (ALKS)
2013 revenues at Alkermes plc totaled $596.3M USD, while annual earnings equaled $1.19 per share.
Quarterly Earnings & Estimates - ALKERMES PLC (ALKS)
Alkermes plc's Quarterly Earnings
Alkermes plc reported 2nd quarter 2014 on 08/2/2014.
Annual Earnings & Estimates - ALKERMES PLC (ALKS)
Alkermes plc's Annual Earnings
Alkermes plc reported annual 2013 earnings of $1.19 per share on 03/1/2014.
Quarterly Revenues - ALKERMES PLC (ALKS)
Annual Revenues - ALKERMES PLC (ALKS)
Alkermes plc's Annual Revenues
Alkermes plc had revenues for the full year 2013 of $596.3M USD. This was 52.9% above the prior year's results.
|Depomed Inc||$26.42 USD||-0.51|
|Emergent BioSolutions Inc||$32.94 USD||-0.35|
|H Lundbeck A/S||kr198.60 DKK||-7.50|
|Impax Laboratories Inc||$40.86 USD||-0.10|
|Jazz Pharmaceuticals PLC||$165.43 USD||-3.39|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|